GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Cash-to-Debt

Fractyl Health (Fractyl Health) Cash-to-Debt : 0.38 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Fractyl Health Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Fractyl Health's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.38.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Fractyl Health couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Fractyl Health's Cash-to-Debt or its related term are showing as below:

GUTS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.35   Med: 1.9   Max: 5.61
Current: 0.38

During the past 5 years, Fractyl Health's highest Cash to Debt Ratio was 5.61. The lowest was 0.35. And the median was 1.90.

GUTS's Cash-to-Debt is ranked worse than
87.67% of 1541 companies
in the Biotechnology industry
Industry Median: 6.49 vs GUTS: 0.38

Fractyl Health Cash-to-Debt Historical Data

The historical data trend for Fractyl Health's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Fractyl Health Cash-to-Debt Chart

Fractyl Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
0.35 1.90 5.61 2.53 0.38

Fractyl Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 2.53 0.74 0.80 0.38

Competitive Comparison of Fractyl Health's Cash-to-Debt

For the Biotechnology subindustry, Fractyl Health's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fractyl Health's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fractyl Health's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Fractyl Health's Cash-to-Debt falls into.


Fractyl Health Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Fractyl Health's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=33.209 / (2.731 + 83.66)
=0.38

Fractyl Health's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=33.209 / (2.731 + 83.66)
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fractyl Health  (NAS:GUTS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Fractyl Health Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Fractyl Health's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Fractyl Health (Fractyl Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fractyl Health Inc (NAS:GUTS) » Definitions » Cash-to-Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
17 Hartwell Avenue, Lexington, MA, USA, 02421
Website
https://www.fractyl.com
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity.